Salicylic Acid and Risk of Colorectal Cancer
Aayah Nounu,
Rebecca C Richmond,
Isobel D Stewart,
Praveen Surendran,
Nicholas J Wareham,
Adam Butterworth,
Stephanie J Weinstein,
Demetrius Albanes,
John A Baron,
John L Hopper,
Jane C Figueiredo,
Polly A Newcomb,
Noralane M Lindor,
Graham Casey,
Elizabeth A Platz,
Loïc Le Marchand,
Cornelia M Ulrich,
Christopher I Li,
Fränzel JB van Dujinhoven,
Andrea Gsur,
Peter T Campbell,
Víctor Moreno,
Pavel Vodicka,
Ludmila Vodickova,
Efrat Amitay,
Elizabeth Alwers,
Jenny Chang-Claude,
Lori C Sakoda,
Martha L Slattery,
Robert E Schoen,
Marc J Gunter,
Sergi Castellví-Bel,
Hyeong-Rok Kim,
Sun-Seog Kweon,
Andrew T Chan,
Li Li,
Wei Zheng,
D Timothy Bishop,
Daniel D Buchanan,
Graham G Giles,
Stephen B Gruber,
Gad Rennert,
Zsofia K Stadler,
Tabitha A Harrison,
Yi Lin,
Temitope O Keku,
Michael O Woods,
Clemens Schafmayer,
Bethany Van Guelpen,
Steven Gallinger,
Heather Hampel,
Sonja I Berndt,
Paul DP Pharoah,
Annika Lindblom,
Alicja Wolk,
Anna H Wu,
Emily White,
Ulrike Peters,
David A Drew,
Dominique Scherer,
Justo Lorenzo Bermejo,
Hermann Brenner,
Michael Hoffmeister,
Ann C Williams,
Caroline L Relton
Nov 22, 2021
Salicylic acid (SA) has observationally been shown to decrease colorectal cancer (CRC) risk. Aspirin (acetylsalicylic acid, that rapidly deacetylates to SA) is an effective primary and secondary chemopreventive agent. Through a...